| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-08 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-08 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-08 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-08 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-08 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-07 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-07 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |